Rachlis, A R. (1988) Neurologic manifestations of HIV infection. Postgrad Med 103: 1–11.Google Scholar

Dal Pan, G J, McArther, J C, Harrison, M J G. (1997) Neurological symptoms in HIV infection. In Berger, J R, Levy, R M (eds). AIDS and Nervous System, 2nd edition. Lippincott-Raven, Philadelphia: 141–172.Google Scholar

Satishchandra, P, Sinha, S. (2008) Seizures in HIV seropositive individuals: NIMHANS experience and review. Epilepsia 49(S6): 33–41.CrossRefGoogle ScholarPubMed

Satishchandra, P, Sinha, S. (2011) Seizures in HIV seropositive individuals. In Shorvon, S, Guerrini, R, Andermann, F (eds). The Causes of Epilepsy. Cambridge University Press, Cambridge: Chapter 75, 520–527.Google Scholar

Romanelli, F, Ryan, M. (2002) Seizures in HIV seropositive individuals: epidemiology and treatment. CNS Drugs 16: 91–98.CrossRefGoogle ScholarPubMed

Romanelli, F, Jennings, H R, Nath, A, Ryan, M, Berger, J. (2000) Therapeutic dilemma: the use of anticonvulsants in HIV positive individuals. Neurology 54: 1404–1407.CrossRefGoogle ScholarPubMed

Levy, R M, Bredesen, D E, Rosenblum, M L. (1985) Neurological manifestations of acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg 65: 475–496.CrossRefGoogle Scholar

Garg, R K. (1999) HIV medicine: HIV infection and seizures. Postgrad Med J 75: 387–390.CrossRefGoogle Scholar

Kellinghaus, C, Engbring, C, Kovac, S, et al. (2008) Frequency of seizures and epilepsy in neurological HIV-infected patients. Seizure 17: 23–33.CrossRefGoogle ScholarPubMed

Sinha, S, Satishchandra, P, Nalini, A, et al. (2005) New-onset seizures among HIV infected drug naïve patients from south India. Neurology Asia 10: 29–33.Google Scholar

Chadha, D S, Handa, A, Sharma, S K, Varadarajulu, Singh A P. (2000) Seizures in patients with HIV infection. J Assoc Physicians India 48: 573–576.Google Scholar

Pascual-Sedano, B, Iranzo, A, Marti-Fabregas, J, et al. (1999) Prospective study of new onset seizures in patients with HIV infection: etiologic and clinical aspects. Arch Neurol 56: 609–612.CrossRefGoogle ScholarPubMed

Yacoob, Y, Bhigjee, A I, Moodley, P, Parboosing, R. (2011) Sodium valproate and highly active antiretroviral therapy in HIV positive patients who develop new onset seizures. Seizure 20: 80–82.CrossRefGoogle ScholarPubMed

Modi, G, Modi, M, Martinus, I, Saffer, D. (2000) New onset seizures associated with HIV infection. Neurology 55: 1558–1561.CrossRefGoogle ScholarPubMed

Holtzman, D M, Kaku, D A, So, Y T. (1989) New-onset seizures associated with human immunodeficiency virus infection: causation and clinical features in 100 cases. Am J Med 87: 173–177.CrossRefGoogle ScholarPubMed

Wong, M C, Suite, N D A, Labar, D R. (1990) Seizures in human immunodeficiency virus infection. Arch Neurol 47: 640–642.CrossRefGoogle ScholarPubMed

Van Paesschen, W, Bodian, C, Maker, H. (1995) Metabolic abnormalities and new-onset seizures in human immunodeficiency virus-seropositive patients. Epilepsia 36: 146–150.Google Scholar

Pesola, G R, Westfal, R E. (1998) New onset generalized seizures with AIDS presenting at an emergency department. Acad Emerg Med 5: 905–911.Google Scholar

Dore, G J, Law, M G, Brew, B J. (1996) Prospective analysis of seizures occurring in human immunodeficiency virus type-1 infection. J Neuro AIDS 1: 59–69.Google Scholar

Samia, P, Petersen, R, Walker, K G, Eley, B, Wilmshurst, J M. (2013) Prevalence of seizures in children infected with human immunodeficiency virus J Child Neurol 28: 297–302.CrossRefGoogle ScholarPubMed

Delanty, N, Vaughan, C J, French, J A. (1998) Medical causes of seizures. Lancet 352: 383–390.CrossRefGoogle ScholarPubMed

Shobha, N, Satishchandra, P, Desai, A, et al. (2006) Seizure as the initial manifestation of cerebral toxoplasmosis in HIV clade C infected patients. Presented at an International Continued Medical Education conference, Chennai.Google Scholar

Shyambabu, C, Satishchandra, P, Mahadevan, A, et al. (2013) Usefulness of stereotactic biopsy and neuroimaging in management of HIV-1 Clade C associated focal brain lesions with special focus on cerebral toxoplasmosis. Clin Neurol Neurosurg 115: 995–1002.Google Scholar

Report of the Quality Standards Subcommittee of the American Academy of Neurology. (1998) Evaluation and management of intracranial mass lesions in AIDS. Neurology 50: 21–26.CrossRefGoogle Scholar

Aronow, H A, Feraru, E R, Lipton, R B. (1989) New-onset seizures in AIDS patients: etiology, prognosis, and treatment. Neurology 39(Suppl 1): 428.Google Scholar

Provenzale, J M, Jinkins, J R. (1997) Brain and spine imaging findings in AIDS patients. Radiol Clin North Am 35: 1127–1166.CrossRefGoogle ScholarPubMed

USPHS/IDSA. (1999) 1999 guidelines for the prevention and treatment of opportunistic infections in persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 48(RR10): 1–59.Google Scholar

Millogo, A, Lankoande, D, Yameogo, I, et al. (2004) New-onset seizures in patients with immunodeficiency virus infection in Bobo-Dioulasso Hospital. Bull Soc Pathol Exot 97: 268–270.Google Scholar

Daikos, G L, Cleary, T, Rodriguez, A, Fischl, M A. (2003) Multidrug-resistant tuberculous meningitis in patients with AIDS. Int J Tuberc Lung Dis 7: 394–398.Google Scholar

Satishchandra, P, Mathew, P, Gadre, G, et al. (2007). Cryptococcal meningitis: clinical, diagnostic and therapeutic over views. Neurol India 55: 226–232.CrossRefGoogle Scholar

Shobha, N, Satishchandra, P, Mahadevan, A, et al. (2005). Clinical, radiological and pathological features of progressive multifocal leukoencephalopathy (PML) associated HIV Clade C infection. Presented at an International Conference on CNS Opportunistic Infections Associated with HIV at International AIDS symposia, Frascati, Italy.Google Scholar

Netravathi, M, Mahadevan, A, Satishchandra, P, et al. (2013) Progressive multifocal leukoencephalopathy (PML) associated with HIV Clade C is not uncommon. J Neurovirol 19: 198–208.Google Scholar

Moulignier, A, Mikol, J, Pialoux, G, et al. (1995) AIDS-associated progressive multifocal leukoencephalopathy revealed by new-onset seizures. Am J Med 99: 64–68.CrossRefGoogle ScholarPubMed

Tellechea-Rotta, N, Legido, A. (2003) Acquired immunodeficiency syndrome by vertical transmission: neurological disorders. Rev Neurol 36: 255–263.Google Scholar

Tardieu, M, Le Chenadec, J, Persoz, A, et al. (2000) HIV-1-related encephalopathy in infants compared with children and adults. French Pediatric HIV Infection Study and the SEROCO Group. Neurology 54: 1089–1095.Google Scholar

Ozkaya, G, Kurne, A, Unal, S, et al. (2006) Aphasic status epilepticus with periodic lateralized epileptiform discharges in a bilingual patient as a presenting sign of “AIDS-toxoplasmosis complex”. Epilepsy Behav 9: 193–196.Google Scholar

Cury, R F, Wichert-Ana, L, Sakamoto, A C, Fernandes, R M. (2004) Focal non-convulsive status epilepticus associated to PLEDs and intense focal hyperemia in an AIDS patient. Seizure 13: 358–361.Google Scholar

Sinha, S, Satishchandra, P. (2003) Nervous system involvement in asymptomatic HIV seropositive individuals – a cognitive and electrophysiological study. Neurology (India) 51: 466–469.Google Scholar

Enzenberger, W, Fischer, P A, Helm, E B, Stille, W. (1985) Value of EEG in AIDS. Lancet 325(8436): 1047–1048.CrossRefGoogle Scholar

Udgirkar, V S, Tullu, M S, Bavdekar, S B, et al. (2003) Neurological manifestations of HIV infection. Indian Pediatr 40: 230–234.Google Scholar

Navia, B, Jordan, B, Price, R. (1986) The AIDS dementia complex: I. Clinical features. Ann Neurol 19: 517–524.Google Scholar

Lipton, S A. (1994) HIV-related neuronal injury. Molec Neurobiol 8(2–3):181–196.CrossRefGoogle ScholarPubMed

Patsalos, P N, Perucca, E. (2003) Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol 2(8): 473–481.Google Scholar

Panel on Clinical Practice for Treatment of HIV Infection convened by the Department of Health and Human Services (DHHS) and the Henry J. Kaiser Family Foundation. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Available from: www.hivatis.org/Google Scholar

Moog, C, Kuntz-Simon, G, Caussin-Schwemling, C, et al. (1996) Sodium valproate, an anticonvulsant drug, stimulates human immunodeficiency virus type 1 replication independently of glutathione levels. J Gen Virol 196: 496–505.Google Scholar

Liedtke, M D, Lockhart, S M, Rathbun, R C. (2004) Anticonvulsant and antiretroviral interactions. Ann Pharmacother 38: 482–489.CrossRefGoogle ScholarPubMed

Yacoob, Y, Bhigjee, A I, Moodley, P B, Parboosing, R. (2011) Sodium valproate and highly active antiretroviral therapy in HIV positive patients who develop new onset seizures. Seizure 20: 80–82.CrossRefGoogle ScholarPubMed

Birbeck, G L, French, J A, Perucca, E, et al. (2012) Antiepileptic drug selection for people with HIV/AIDS: evidence-based guidelines from the ILAE and AAN. Epilepsia 53: 207–214.Google Scholar

Siddiqi, O, Birbeck, G L. (2013) Safe treatment of seizures in the setting of HIV/AIDS. Curr Treat Options Neurol 15: 529–543.Google Scholar